Rare diseases
Investigational molecules
Locations
Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
The NetherlandsStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
The NetherlandsPhase 1b Study of CC-90010 with Temozolomide in Adults with Newly Diagnosed Glioblastoma After Surgery
The NetherlandsEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
The NetherlandsWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
The NetherlandsPhase 3 Study of INCB123667 versus investigator's choice of chemotherapy drug combination in patients with platinum‑resistant ovarian cancer and cyclin E1 overexpression
The NetherlandsA study to evaluate the safety and effectiveness of AZD9750 and saruparib in patients with metastatic prostate cancer
The NetherlandsStudy of tarlatamab and durvalumab compared to durvalumab alone for patients with extensive stage small cell lung cancer
The NetherlandsA study to evaluate the effectiveness and safety of zasocitinib in patients with moderate to severe hidradenitis suppurativa
The NetherlandsSacituzumab Tirumotecan in Recurrent or Metastatic Cervical Cancer After Platinum Chemotherapy and Anti-PD-L1 or Anti-PD-1 Therapy
The NetherlandsEfficacy and Safety Evaluation of Tulisokibart in Moderate to Severe Hidradenitis Suppurativa: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Trial
The NetherlandsA Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
